# Amiloride Clinical Trial In Optic Neuritis

> **NCT01802489** · PHASE2 · COMPLETED · sponsor: **University of Oxford** · enrollment: 46 (actual)

## Conditions studied

- Optic Neuritis
- Multiple Sclerosis

## Interventions

- **DRUG:** Amiloride
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01802489
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2018-05-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01802489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01802489, "Amiloride Clinical Trial In Optic Neuritis". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT01802489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*